Our company is a high-tech enterprise engaged in technology development and manufacture of chiral reagents, chiral organic chemical intermediate products, chiral medical primary products and specializes in chiral technology industrialization. Supported by the National Engineering Research Center for Chiral Drugs, the company has strong research and development capabilities in the field of chiral products to meet various market demands and has successfully commercialized a number of chiral products, including optical active tartaric derivatives, chiral diamine, chiral aminoalcohols. The company is actively pursuing national and international collaboration to expand the chiral technology to new applications.
Our main products: Di-m-toluoyl-L-tartaric acid, Di-m-toluoyl-D-tartaric acid, Di-o-toluoyl-D-tartaric acid, Di-o-toluoyl-L-tartaric acid, (1S,2S)-(+)-N-p-Tosyl-1,2-diphenylethylenediamine 167316-27-0, (1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine 144222-34-4, (R)-1,2,3,4-tetrahedro-naphthoic acid 23357-47-3, (S)-1,2,3,4-tetrahedro-naphthoic acid 85977-52-2, (1R,2S)-(-)-2-Amino-1,2-diphenylethanol 23190-16-1, (1S,2R)-(+)-2-Amino-1,2-diphenylethanol 23364-44-5, (S)-(-)-2-Carboxy-tetrahydrofuroic-acid 87392-07-2, (R)-(+)-2-Carboxy-tetrahydrofuroic-acid 87392-05-0,(1S,2S)-(-)-1,2-Diphenylethylenediamine 29841-69-8, (1R,2R)-(+)-1,2-Diphenylethylenediamine 35132-20-8, Dibenzoyl-(-)-P-methoxy-L-tartaric acid 50583-51-2, Dibenzoyl-(+)-P-methoxy-D-tartaric acid 191605-10-4, Dibenzoyl-L-tartaric acid monohydrate 62708-56-9, Dibenzoyl-D-tartaric acid monohydrate 80822-15-7, Di-p-toluoyl-L-tartaric acid monohydrate, Di-p-toluoyl-D-tartaric acid monohydrate 71607-32-4, Diisoprropyl-L-tartrate 2217-15-4, Diisoprropyl-D-tartrate 62961-64-2, Dibenzoyl-L-tartaric acid 2743-38-6, Dibenzoyl-D-tartaric acid 17026-42-5, Di-p-toluoyl-L-tartaric acid 32634-66-5, Di-p-toluoyl-D-tartaric acid 32634-68-7, Dimethyl-L-tartrate 608-68-4, Dimethyl-D-tartrate 13171-64-7, Diethyl-L-tartrate 87-91-2, Diethyl-D-tartrate 13811-71-7.